Tomasello Shawn insider trades
Tomasello Shawn has filed 25 Form 4s with the SEC that we hold, for GMDA (Director), Cabaletta Bio, Inc. (CABA) (Director), 4D Molecular Therapeutics, Inc. (FDMT) (Director) and Kalaris Therapeutics, Inc. (ALVR) (Director), among 5 companies in all. Across all of them we count 2 purchases worth $65.2K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($50.2K) and 0 sales ($0). The largest single trade was a purchase of 22,725 shares of Cabaletta Bio, Inc. worth $50.2K, dated 2026-01-21. The first filing on our record is dated 2021-12-10 and the latest 2026-06-18.
GMDA
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-09-30 | P, purchase reported on Form 4 | 9,677 | $15.0K | 2022-10-04 |
Cabaletta Bio, Inc. (CABA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-01-21 | P, purchase reported on Form 4 | 22,725 | $50.2K | 2026-01-21 |
4D Molecular Therapeutics, Inc. (FDMT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Kalaris Therapeutics, Inc. (ALVR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
TCRR
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1617239) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms